1
|
Hong E, Hu R, Posligua A, Choate K, Durkin JR. Acral hemorrhagic Darier disease: A case report of a rare presentation and literature review. JAAD Case Rep 2023; 31:93-96. [PMID: 36545487 PMCID: PMC9762068 DOI: 10.1016/j.jdcr.2022.05.030] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022] Open
Affiliation(s)
- Emily Hong
- University of New Mexico School of Medicine, Albuquerque, New Mexico
| | - Ronghua Hu
- Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut
- Department of Genetics, Yale University School of Medicine, New Haven, Connecticut
- Department of Pathology, Yale University School of Medicine, New Haven, Connecticut
| | - Alba Posligua
- Department of Dermatology, University of New Mexico School of Medicine, Albuquerque, New Mexico
| | - Keith Choate
- Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut
- Department of Genetics, Yale University School of Medicine, New Haven, Connecticut
- Department of Pathology, Yale University School of Medicine, New Haven, Connecticut
| | - John R. Durkin
- Department of Dermatology, University of New Mexico School of Medicine, Albuquerque, New Mexico
- Correspondence to: John R. Durkin, MD, MBA, Department of Dermatology, University of New Mexico School of Medicine, 1021 Medical Arts Ave NE, Albuquerque, NM 87102.
| |
Collapse
|
2
|
Hong E, Posligua A, Elwood H, Smidt AC. Excimer laser treatment for morphea-lichen sclerosus et atrophicus overlap in a pediatric patient. JAAD Case Rep 2022; 32:96-98. [PMID: 36698372 PMCID: PMC9867949 DOI: 10.1016/j.jdcr.2022.12.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022] Open
Affiliation(s)
- Emily Hong
- University of New Mexico, School of Medicine, Albuquerque, New Mexico
| | - Alba Posligua
- Department of Dermatology, University of New Mexico School of Medicine, Albuquerque, New Mexico
| | - Hillary Elwood
- Department of Dermatology, University of New Mexico School of Medicine, Albuquerque, New Mexico,Pathology Associates of Albuquerque, Albuquerque, New Mexico,Department of Pathology, University of New Mexico School of Medicine, Albuquerque, New Mexico
| | - Aimee C. Smidt
- Department of Dermatology, University of New Mexico School of Medicine, Albuquerque, New Mexico,Department of Pediatrics, University of New Mexico School of Medicine, Albuquerque New Mexico,Correspondence to: Aimee C. Smidt, MD, Chair, Professor of Dermatology and Pediatrics, Founding Director, Department of Dermatology, Vascular Anomalies Clinic, University of New Mexico School of Medicine, 1021 Medical Arts Ave NE, Albuquerque, NM 87102.
| |
Collapse
|
4
|
Zagelbaum Ward NK, Linares-Koloffon C, Posligua A, Gandrabur L, Kim WY, Sperber K, Wasserman A, Ash J. Cardiac Manifestations of Systemic Lupus Erythematous: An Overview of the Incidence, Risk Factors, Diagnostic Criteria, Pathophysiology and Treatment Options. Cardiol Rev 2022; 30:38-43. [PMID: 32991394 DOI: 10.1097/crd.0000000000000358] [Citation(s) in RCA: 14] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
Systemic lupus erythematosus (SLE) is a complex connective tissue disease that can potentially affect every organ of the human body. In some cases, SLE may present with diverse cardiac manifestations including pericarditis, myocarditis, valvular disease, atherosclerosis, thrombosis, and arrhythmias. Heart disease in SLE is associated with increased morbidity and mortality. It is unclear whether traditional treatments for coronary artery disease significantly impact mortality in this population. Current therapeutic agents for SLE include glucocorticoids, hydroxychloroquine, mycophenolate mofetil, azathioprine, methotrexate, cyclophosphamide, and B cell-directed therapies. This article will provide a comprehensive review and update on this important disease state.
Collapse
Affiliation(s)
- Nicole K Zagelbaum Ward
- From the Department of Rheumatology, Keck School of Medicine/University of Southern California, Los Angeles, CA
| | - Carlos Linares-Koloffon
- Yale Center for Asthma and Airway Disease, Yale University School of Medicine, New Haven, CT
| | - Alba Posligua
- Department of Medicine and Division of Rheumatology, Westchester Medical Center and New York Medical College, Valhalla, NY
| | - Liliya Gandrabur
- Department of Medicine and Division of Rheumatology, Westchester Medical Center and New York Medical College, Valhalla, NY
| | - Woo Young Kim
- Department of Medicine and Division of Rheumatology, Westchester Medical Center and New York Medical College, Valhalla, NY
| | - Kirk Sperber
- Department of Medicine and Division of Rheumatology, Westchester Medical Center and New York Medical College, Valhalla, NY
| | - Amy Wasserman
- Department of Medicine and Division of Rheumatology, Westchester Medical Center and New York Medical College, Valhalla, NY
| | - Julia Ash
- Department of Medicine and Division of Rheumatology, Westchester Medical Center and New York Medical College, Valhalla, NY
| |
Collapse
|
5
|
Micheletti RG, Chiesa-Fuxench Z, Noe MH, Stephen S, Aleshin M, Agarwal A, Boggs J, Cardones AR, Chen JK, Cotliar J, Davis MDP, Dominguez A, Fox LP, Gordon S, Hamrick R, Ho B, Hughey LC, Jones LM, Kaffenberger BH, Kindley K, Kroshinsky D, Kwong BY, Miller DD, Mostaghimi A, Musiek A, Ortega-Loayza AG, Patel R, Posligua A, Rani M, Saluja S, Sharon VR, Shinkai K, John JS, Strickland N, Summers EM, Sun N, Wanat KA, Wetter DA, Worswick S, Yang C, Margolis DJ, Gelfand JM, Rosenbach M. Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Multicenter Retrospective Study of 377 Adult Patients from the United States. J Invest Dermatol 2018; 138:2315-2321. [PMID: 29758282 DOI: 10.1016/j.jid.2018.04.027] [Citation(s) in RCA: 58] [Impact Index Per Article: 9.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/19/2017] [Revised: 03/14/2018] [Accepted: 04/05/2018] [Indexed: 12/19/2022]
Abstract
Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) is a rare, severe mucocutaneous reaction with few large cohorts reported. This multicenter retrospective study included patients with SJS/TEN seen by inpatient consultative dermatologists at 18 academic medical centers in the United States. A total of 377 adult patients with SJS/TEN between January 1, 2000 and June 1, 2015 were entered, including 260 of 377 (69%) from 2010 onward. The most frequent cause of SJS/TEN was medication reaction in 338 of 377 (89.7%), most often to trimethoprim/sulfamethoxazole (89/338; 26.3%). Most patients were managed in an intensive care (100/368; 27.2%) or burn unit (151/368; 41.0%). Most received pharmacologic therapy (266/376; 70.7%) versus supportive care alone (110/376; 29.3%)-typically corticosteroids (113/266; 42.5%), intravenous immunoglobulin (94/266; 35.3%), or both therapies (54/266; 20.3%). Based on day 1 SCORTEN predicted mortality, approximately 78 in-hospital deaths were expected (77.7/368; 21%), but the observed mortality of 54 patients (54/368; 14.7%) was significantly lower (standardized mortality ratio = 0.70; 95% confidence interval = 0.58-0.79). Stratified by therapy received, the standardized mortality ratio was lowest among those receiving both steroids and intravenous immunoglobulin (standardized mortality ratio = 0.52; 95% confidence interval 0.21-0.79). This large cohort provides contemporary information regarding US patients with SJS/TEN. Mortality, although substantial, was significantly lower than predicted. Although the precise role of pharmacotherapy remains unclear, co-administration of corticosteroids and intravenous immunoglobulin, among other therapies, may warrant further study.
Collapse
Affiliation(s)
- Robert G Micheletti
- Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.,Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - Zelma Chiesa-Fuxench
- Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - Megan H Noe
- Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - Sasha Stephen
- Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - Maria Aleshin
- Division of Dermatology, University of California–Los Angeles, Los Angeles, California, USA
| | - Ashwin Agarwal
- Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - Jennifer Boggs
- Department of Dermatology, Mayo Clinic, Rochester, Minnesota, USA
| | - Adela R Cardones
- Department of Dermatology, Duke University, Durham, North Carolina, USA
| | - Jennifer K Chen
- Department of Dermatology, Stanford Hospital and Clinics, Redwood City, California, USA
| | | | - Mark D P Davis
- Department of Dermatology, Mayo Clinic, Rochester, Minnesota, USA
| | - Arturo Dominguez
- Department of Dermatology, University of Texas, Southwestern, Dallas, Texas, USA
| | - Lindy P Fox
- Department of Dermatology, University of California–San Francisco, San Francisco, California, USA
| | - Shayna Gordon
- Division of Dermatology, Washington University School of Medicine, St. Louis, Missouri, USA
| | - Ronald Hamrick
- Department of Dermatology, University of Minnesota, Minneapolis, Minnesota, USA
| | - Baran Ho
- Department of Dermatology, University of California–Davis, Davis, California, USA
| | - Lauren C Hughey
- Department of Dermatology, University of Alabama, Birmingham, Birmingham, Alabama, USA
| | - Larry M Jones
- Department of Surgery, Ohio State University College of Medicine, Columbus, Ohio, USA
| | | | - Kimball Kindley
- Department of Dermatology, University of Virginia, Charlottesville, Virginia, USA
| | - Daniela Kroshinsky
- Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts, USA
| | - Bernice Y Kwong
- Department of Dermatology, Stanford Hospital and Clinics, Redwood City, California, USA
| | - Daniel D Miller
- Department of Dermatology, University of Minnesota, Minneapolis, Minnesota, USA
| | - Arash Mostaghimi
- Department of Dermatology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA
| | - Amy Musiek
- Division of Dermatology, Washington University School of Medicine, St. Louis, Missouri, USA
| | - Alex G Ortega-Loayza
- Department of Dermatology, Oregon Health & Science University, Portland, Oregon, USA
| | - Raj Patel
- True Dermatology, Alabaster, Alabama, USA
| | - Alba Posligua
- Department of Dermatology, State University of New York–Buffalo, Buffalo, New York, USA
| | - Monica Rani
- Dermatology and Aesthetics, Chicago, Illinois, USA
| | - Sandeep Saluja
- Department of Dermatology, University of Utah, Salt Lake City, Utah, USA
| | - Victoria R Sharon
- Department of Dermatology, Hofstra Northwell School of Medicine, New Hyde Park, New York, USA
| | - Kanade Shinkai
- Department of Dermatology, University of California–San Francisco, San Francisco, California, USA
| | - Jessica St John
- Department of Dermatology, Harvard University, Boston, Massachusetts, USA
| | - Nicole Strickland
- Department of Dermatology, University of Texas, Southwestern, Dallas, Texas, USA
| | - Erika M Summers
- Department of Dermatology, University of Utah, Salt Lake City, Utah, USA
| | - Natalie Sun
- Department of Dermatology, University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, USA
| | - Karolyn A Wanat
- Department of Dermatology, University of Iowa, Iowa City, Iowa, USA
| | - David A Wetter
- Department of Dermatology, Mayo Clinic, Rochester, Minnesota, USA
| | - Scott Worswick
- Division of Dermatology, University of California–Los Angeles, Los Angeles, California, USA
| | - Caroline Yang
- Department of Dermatology, Brown University, Providence, Rhode Island, USA
| | - David J Margolis
- Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - Joel M Gelfand
- Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA
| | - Misha Rosenbach
- Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.,Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
| |
Collapse
|
7
|
Kiguradze T, Bruins FM, Guido N, Bhattacharya T, Rademaker A, Florek AG, Posligua A, Amin S, Laumann AE, West DP, Nardone B. Evidence for the association of Hashimoto's thyroiditis with psoriasis: a cross-sectional retrospective study. Int J Dermatol 2017; 56:553-556. [PMID: 28217937 DOI: 10.1111/ijd.13459] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/03/2016] [Revised: 06/30/2016] [Accepted: 08/22/2016] [Indexed: 12/21/2022]
Abstract
BACKGROUND Current information indicates that psoriasis is a metabolic disorder with systemic manifestations. Reports have revealed an association between psoriasis and several chronic autoimmune disorders. For one of these disorders, Hashimoto's thyroiditis (HT), there are scarce, and relatively unconfirmed, reports of an association with psoriasis. We sought to determine if such an association is detectable in a large medical record data repository. METHODS We searched one institution's electronic medical record data repository from January 2010 to December 2013. Patients were identified by ICD-9 codes (psoriasis: 696.0; 696.1, HT: 245.2). Only data from patients with laboratory-confirmed HT (anti-thyroid peroxidase [anti-TPO] antibodies; thyroglobulin antibodies; serum thyroid-stimulating hormone; and free T3) were eligible for inclusion. Logistic regression analysis was used to obtain an odds ratio (OR) to establish an association between psoriasis and HT. Stratified analyses were performed to test for confounding variable and effect modification. RESULTS Medical records for 856,615 individuals with documented encounters between January 1, 2010, and December 31, 2013, were detected. A total of 9654 had a diagnosis of psoriasis, and 1745 had a diagnosis of HT. Of these, 41 subjects were diagnosed with both conditions. A significant association existed for psoriasis and HT, even after adjusting for confounding variables that included gender, age, psoriatic arthropathy, and the use of systemic anti-psoriatic agents (OR = 2.49; 95% CI 1.79-3.48; P < 0.0001). CONCLUSIONS This association has broad clinical impact and deserves further attention with regard to patient care, clinical research, and developmental therapeutics.
Collapse
Affiliation(s)
- Tina Kiguradze
- Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
| | - Finola M Bruins
- Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
| | - Nicholas Guido
- Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
| | - Tanya Bhattacharya
- Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
| | - Alfred Rademaker
- Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
| | - Aleksandra G Florek
- Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
| | - Alba Posligua
- Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
| | - Shatil Amin
- Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
| | - Anne E Laumann
- Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
| | - Dennis P West
- Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
| | - Beatrice Nardone
- Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
| |
Collapse
|